OSIR : Summary for Osiris Therapeutics, Inc. - Yahoo Finance

We are experiencing some temporary issues. The market data on this page are currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. Markets closed

Osiris Therapeutics, Inc. (OSIR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.91 0.00 (0.00%)
At close: 4:00PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close 4.91
Open 4.87
Bid 0.00 x
Ask 0.00 x
Day's Range 4.87 - 5.00
52 Week Range 3.55 - 7.87
Volume 44,498
Avg. Volume 194,325
Market Cap 169.16M
Beta 1.00
PE Ratio (TTM) 116.90
EPS (TTM) 0.04
Earnings Date Mar 23, 2016 - Mar 24, 2016
Dividend & Yield 0.00 (0.00%)
Ex-Dividend Date N/A
1y Target Est 4.00
Trade prices are not sourced from all markets
  • Is Osiris Therapeutics, Inc. (OSIR) A Good Stock To Buy?
    Insider Monkey 29 days ago

    Is Osiris Therapeutics, Inc. (OSIR) A Good Stock To Buy?

    It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not gamble the hard-earned money of the people who are on the edge of poverty. Truth […]

  • American City Business Journals 2 months ago

    Osiris Therapeutics offers first glimpse into its books since last year

    Osiris Therapeutics Inc. stock soared more than 20 percent Tuesday morning after it gave the first glimpse into its balance sheet since last year. The publicly traded Columbia biotech has not filed a financial report since last November, when it reported a $685,000 loss in the third quarter of 2015. Osiris began reviewing its 2014 and 2015 financial statements after its auditor resigned last December.

  • optionMONSTER 3 months ago

    Will Osiris extend downward trend?

    A trader is preparing for more downside potential in Osiris Therapeutics. OptionMonster's monitoring system detected the purchase of 2,000 February 4 puts for $0.60 at the same time yesterday. This is ...

  • Osiris Therapeutics, Inc. (OSIR) Stock Discontinues Trial Enrollment
    Insider Monkey 3 months ago

    Osiris Therapeutics, Inc. (OSIR) Stock Discontinues Trial Enrollment

    Osiris Therapeutics, Inc. (NASDAQ:OSIR) took it on the chin yesterday morning after the company released news through an 8-K filing. Today, we’ll talk about that news, what we’re currently seeing from the stock, and what we can expect to see from OSIR ahead. OSIR Announces Enrollment Termination Through 8-K Filing While most big news is […]

  • Stocks pare May gains as rate hike case builds
    Yahoo Finance 8 months ago

    Stocks pare May gains as rate hike case builds

    Stocks trim gains for the month of May as strong data has traders eying the Fed. Could this week job's report push the Fed over the rate hike edge? Catch The Final Round at 4p ET with Jen Rogers and markets correspondent Nicole Sinclair.

  • TheStreet.com 8 months ago

    MiMedx Goes After Osiris With Lawsuit

    The wound care provider filed the suit for allegedly falsifying and misleading consumers with clinical data.

  • 24/7 Wall St. 10 months ago

    The 52-Week Low Club for Wednesday

    March 9, 2016: Here are four stocks trading with heavy volume among 26 equities making new 52-week lows in Wednesday’s session. Unisys Corp. (NYSE: UIS) fell by nearly 28% on Wednesday to post a new 52-week ...

  • Motley Fool 11 months ago

    Why Shares of Osiris Therapeutics Tanked Today

    A shake-up in leadership sent the stock reeling.

  • Investopedia 11 months ago

    The Top 5 Micro Cap Biotechnology Stocks for 2016 (BSTC, OSIR)

    Discover some of the most promising micro-cap biotechnology stocks that investors can consider for their 2016 investment portfolio.